Singapore
Hello, I am a Biological Sciences graduate from NTU who has cumulated various laboratory experiences in both the benchtop and clinical setting. I am currently employed with TLL as an assistant research officer. Besides having an interest in research and development, I am open to exploring other roles in the life science industry.
• Performed physiological plant assays involving various nutrient and chemicals. • Utilized various sensor technologies for data acquisition: VIS-NIR and Raman spectroscopy, hyperspectral imaging, handheld sensors (SPAD, Li-COR). • Conducted biochemical extraction and quantification procedures of plant-related compounds. • Acquired experience with basic molecular techniques and procedures such as cloning, RNA extraction, qPCR, genotyping. • Played a secondary role of a lab buyer that requires the active liaison between internal users, central procurement, external vendors and finance team for the procurement of products/services in a timely manner • Performed a secondary role of a lab safety coordinator to ensure workplace and user adherence to safety guidelines and regulations.
I was attached to the department of pediatric anesthesia, while under the mentorship of Dr Bong Choon Looi, I had the opportunity to: • Independently facilitate clinical study processes including patient screening, recruitment, follow up and documentation. • Organize and categorize EEG recordings for its subsequent analysis. • Perform secondary analysis of previously collected clinical data using SPSS statistics.
• Guided primary school students in the basics of English grammar and vocabulary. • Enhanced students' creative writing techniques through constructive criticism.
• Explored the transduction profile of AAV2 in the adult mouse cerebellum using immunohistochemistry and confocal microscopy. • Determined the viability of utilizing AAV2 to study cerebellar associated functions through genetic manipulations. • Executed video-based behavioural analysis for at least 200 hours of recordings.
• Developed drug-resistant cell lines (Hut78) at intervals of 3-7 days to understand the molecular basis of de novo drug resistance in the treatment of cutaneous T-cell lymphoma.